Myeloperoxidase (MPO) – possible diagnosis biomarker and risk stratification in myocardial inotropism deficit induced by chronic ischemic heart disease

Myeloperoxidase (MPO) – possible diagnosis biomarker and risk stratification in myocardial inotropism deficit induced by chronic ischemic heart disease

The myeloperoxidase levels of 208 patients with ischemic heart disease hospitalized for congestive heart failure were tested at admission, and discharge after 14 days. The calculations for the serum average concentration/lot/date, were made, subsequent, using the values of the tested parameters rega...

Full description

Bibliographic Details
Main Authors: Gabi Valeriu Dinca, Adriana Diaconu, Bogdan-Ioan Coculescu, Gheorghe Manole, Horatiu Vultur, Elena Claudia Coculescu
Format: Article
Language:English
Published: Amaltea Medical Publishing House 2022-09-01
Series:Romanian Journal of Medical Practice
Subjects:
myeloperoxidase (mpo)
chronic ischemic cardiomyopathy
inotropism deficiency
oxidative stress
Online Access:https://rjmp.com.ro/articles/2022.3/RJMP_2022_3_Art-04.pdf

Internet

https://rjmp.com.ro/articles/2022.3/RJMP_2022_3_Art-04.pdf

Similar Items